Keyword: Oklahoma

Judge Thad Balkman in Oklahoma reduced J&J's opioid verdict to $465 million to cover one year of crisis abatement, WSJ reports.

Oklahoma politicians contend J&J should be on the line for future abatement costs even after a $572 million verdict, but J&J sees things differently.

A bellwether trial for thousands of opioid lawsuits is set to begin today. With settlement talks swirling, will the trial end before it begins?

J&J's $572 million opioid verdict in Oklahoma is both a "landmark" ruling and not overwhelmingly significant, experts said.

Should Johnson & Johnson owe billions to fix Oklahoma's opioid crisis? After weeks of trial testimony, a judge will have his say Monday afternoon.

After J&J's failed bid to toss out its Oklahoma marketing suit, analysts are wondering how high opioid settlements could go. Short answer: Who knows?

J&J has received its fair share of barbs Oklahoma's bench trial. Whether it'll be held responsible for the state's opioid crisis is now up to a judge.

After prosecutors wrapped up in Oklahoma, J&J kicked up an argument to toss the case altogether. The judge didn't buy it.

As the first major opioid trial was set to begin, Teva struck an $85 million settlement, about one-third what painkiller giant Purdue Pharma agreed to pay.